Protein Kinase C Beta II Expression in Diffuse Large B-Cell Lymphoma Predicts for Inferior Outcome of Anthracycline-Based Chemotherapy With And Without Rituximab
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E31
DOI: 10.3816/clm.2009.n.093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Harshal Nandurkar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nandurkar, H., Chaiwatanatorn, K., Stamaratis, G., Opeskin, K., & Firkin, F. (2009). Protein Kinase C Beta II Expression in Diffuse Large B-Cell Lymphoma Predicts for Inferior Outcome of Anthracycline-Based Chemotherapy With And Without Rituximab. Clinical Lymphoma and Myeloma, 9(6), E31. https://doi.org/10.3816/clm.2009.n.093
Vancouver
Nandurkar H, Chaiwatanatorn K, Stamaratis G, Opeskin K, Firkin F. Protein Kinase C Beta II Expression in Diffuse Large B-Cell Lymphoma Predicts for Inferior Outcome of Anthracycline-Based Chemotherapy With And Without Rituximab. Clinical Lymphoma and Myeloma. 2009;9(6):E31. doi:10.3816/clm.2009.n.093
BibTeX
@article{Nandurkar2009,
author = {Nandurkar, Harshal and Chaiwatanatorn, Kritika and Stamaratis, Georgia and Opeskin, Kenneth and Firkin, Frank},
title = {Protein Kinase C Beta II Expression in Diffuse Large B-Cell Lymphoma Predicts for Inferior Outcome of Anthracycline-Based Chemotherapy With And Without Rituximab},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E31},
doi = {10.3816/clm.2009.n.093}
}
EUVIMED